136 related articles for article (PubMed ID: 7648988)
1. Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.
Hayashi J; Kishihara Y; Yamaji K; Yoshimura E; Ohmiya M; Tani Y; Ikematsu H; Kashiwagi S
Dig Dis Sci; 1995 Aug; 40(8):1837-41. PubMed ID: 7648988
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha.
Morishima I; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Ohki H; Suga T; Ito O
Scand J Gastroenterol; 1995 Aug; 30(8):807-11. PubMed ID: 7481551
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection.
Sawayama Y; Hayashi J; Kawakami Y; Furusyo N; Ariyama I; Kishihara Y; Ueno K; Kashiwagi S
Dig Dis Sci; 1999 Jan; 44(1):163-9. PubMed ID: 9952238
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group.
Naveau S; Balian A; Degos F; Daurat V; Chevret S; Gayno S; Bastie A; Riachi G; Bartolomei-Portal I; Barange K; Moussalli J; Bailly F; Chaumet-Riffaud P; Emilie D
J Hepatol; 1999 Oct; 31(4):612-7. PubMed ID: 10551383
[TBL] [Abstract][Full Text] [Related]
5. Elevation of serum soluble interleukin-2 receptor levels in patients with hepatitis C virus infection.
Kawakami Y; Hayashi J; Ueno K; Ohmiya M; Kishihara Y; Yamaji K; Kashiwagi S
Fukuoka Igaku Zasshi; 1997 Jul; 88(7):274-82. PubMed ID: 9267073
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
8. Differences between interferon-alpha and -beta treatment for patients with chronic hepatitis C virus infection.
Furusyo N; Hayashi J; Ohmiya M; Sawayama Y; Kawakami Y; Ariyama I; Kinukawa N; Kashiwagi S
Dig Dis Sci; 1999 Mar; 44(3):608-17. PubMed ID: 10080158
[TBL] [Abstract][Full Text] [Related]
9. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection.
Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866
[TBL] [Abstract][Full Text] [Related]
10. In subjects with antibody to hepatitis C virus a high serum level of interleukin-2 soluble receptor suggests activity of liver disease.
Gessoni G; Valverde S; Giacomini A; Antico F; Manoni F
J Viral Hepat; 1998 Mar; 5(2):99-103. PubMed ID: 9572034
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
Simsek H; Kadayifci A
J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
[TBL] [Abstract][Full Text] [Related]
14. Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.
Abe S; Narita R; Matsuhashi T; Oto T; Tabaru A; Otsuki M
Eur J Gastroenterol Hepatol; 2008 May; 20(5):373-8. PubMed ID: 18403937
[TBL] [Abstract][Full Text] [Related]
15. Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis C.
Wang J; Xiang GJ; Liu BX
World J Gastroenterol; 2003 Apr; 9(4):751-4. PubMed ID: 12679925
[TBL] [Abstract][Full Text] [Related]
16. Clinical observation of serum IL-18, IL-10 and sIL-2R levels in patients with chronic hepatitis C pre- and post antiviral treatment.
Jia H; Du J; Zhu S; Ma Y; Cai H
Chin Med J (Engl); 2003 Apr; 116(4):605-8. PubMed ID: 12875732
[TBL] [Abstract][Full Text] [Related]
17. Human lymphoblastoid interferon treatment for patients with hepatitis C virus-related cirrhosis.
Furusyo N; Hayashi J; Ueno K; Sawayama Y; Kawakami Y; Kishihara Y; Kashiwagi S
Clin Ther; 1997; 19(6):1352-67. PubMed ID: 9444445
[TBL] [Abstract][Full Text] [Related]
18. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment.
Magrin S; Craxi A; Fabiano C; Simonetti RG; Fiorentino G; Marino L; Diquattro O; Di Marco V; Loiacono O; Volpes R
Hepatology; 1994 Feb; 19(2):273-9. PubMed ID: 8294085
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of hepatitis C viral RNA in liver and serum samples using competitive polymerase chain reaction.
Sugano M; Hayashi Y; Yoon S; Kinoshita M; Ninomiya T; Ohta K; Itoh H; Kasuga M
J Clin Pathol; 1995 Sep; 48(9):820-5. PubMed ID: 7490314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
